Greek Market Community

A Tale of Two Engines: Coca-Cola HBC (EEE.AT) By the end of 2026, the valuation of Coca-Cola HBC (EEE.AT) is projected to reach a "New Normal." The convergence of the Sept 21, 2026, Developed Market upgrade and the formal closing of the CCBA acquisition creates a unique valuation window where the stock sheds its "emerging market discount" while fully pricing in its "African growth premium." ________________________________________ 1. End-of-2026 Target Price Summary Based on the 2027 forward-looking earnings (the metric the market will be pricing in by December 2026), the projected share price is: • DCF-Derived Target (End-2026): €56.40 • Comparables-Derived Target (End-2026): €52.80 • Consensus Year-End Target: €54.60 ________________________________________ 2.Read more

Recommendation: I remain sidelined, NEUTRAL (HOLD );— Slight bearish tilt Rating agencies' views reinforce a mixed picture: post-acquisition upgrades (Fitch to 'B+' IDR with 'BB' notes, Moody's to B2 stable, Morningstar DBRS to B(high) positive trend, S&P to 'B-' stable) reflect improved scale, synergy potential, and deleveraging path, with projected adjusted EBITDA margins largely resilient at 37-38% (S&P over 2025-2027), ~38% (Morningstar DBRS), and above 35% (Fitch pre-revision emphasis on margin expansion via integration). However, Fitch revised its outlook to Negative in December 2025 due to "material exposure to increased UK taxation," which will result in lower-than-previously-expected EBITDA (though not quantified as a sharp margin drop—management mitigated the 2026 impact to ~4% via €84M offsets, revising FY2026 EBITDA guidance to €420-440M from prior higher targets).Read more

Executive Summary Profits doubled (+109%) in H1 2025 , despite geopolitical turbulence. Israel route loss : major blow, as Tel Aviv was a highly profitable market.Read more

This is clearly written as an analysis/opinion , so you won’t have compliance issues posting it as-is. Unibios, through its subsidiary Watera Hellas , has become increasingly involved in water infrastructure upgrades across Greece, particularly with desalination projects on islands facing water scarcity.Read more

Cairo Mezz plays a critical role in the management of non-performing loan (NPL) portfolios. In an environment where investments in secondary markets, particularly in non-performing loans, are gaining increasing attention, Cairo Mezz has demonstrated significant growth and steady performance.Read more

As of the close on January 21, 2026, TITC.AT traded at €54.40, near the upper end of its 52-week range (€33.80–€55.80), with a market capitalization of approximately €4.26 billion. This consolidated report reflects my personal analysis and view, drawing on the latest available data as of this date.Read more

As of the market close on January 20, 2026, Viohalco's shares traded at €12.00, within its 52-week range of €4.70–€12.30, reflecting a market capitalization of approximately €3.2 billion. This personal analysis reflects my view on the stock's undervaluation amid sector headwinds, drawing from real-time data and my proprietary modeling.Read more

As of the market close on January 20, 2026, Cenergy's shares traded at €17.30, at the upper end of its 52-week range of €10.50–€17.32, with a market capitalization of approximately €3.65 billion. This personal analysis underscores my view of the stock's undervaluation, driven by the EU's €1.2 trillion grid modernization push, which amplifies Cenergy's backlog in high-voltage cables and offshore pipes, amid a sector ripe for re-rating.Read more

Disclaimer: As a private investor, I share this personal analysis of Titan Cement for educational purposes. This is NOT investment advice This analysis is provided for informational and educational purposes only.Read more